Table II.

Effect of Treatment on Physiologic Markers

Marker, Mean± SD	No.	Placebo		Active		P*
		Before	After	Before	After
Total carnitine, µmol/L	32	101±23	99±20	104±24	112±23	.06
Total cholesterol, mg/dL	34	171±33	171±36	178±40	177±38	.94
LDL cholesterol, mg/dL	34	89±24	93±24	95±32	97±34	.60
HDL cholesterol, mg/dL	34	49±16	47±15	48±15	46±13	.78
Triglycerides, mg/dL	34	169±120	151±81	179±114	169±120	.50
Fasting glucose, mg/dL	34	104±14	105±24	106±25	104±20	.41
Insulin, IU/mL	32	9.6±7.6	9.1±6.2	12.0±7.9	13.4±11.4	.40
C‐reactive protein, mg/L	27	3.2±3.4	3.3±4.8	2.1±2.6	2.8±3.3	.23
Urine F2‐isoprostanes, ng/mg creatinine	16	1.2±0.8	1.1±0.5	1.0±0.4	1.1±0.6	.96
*Overall P for repeated‐measures analysis of variance. HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein.